Perspectivas del mercado y visión de analista:
Un dispositivo de estimulación de la médula espinal es un dispositivo implantado que alivia el dolor transmitiendo señales eléctricas de bajo nivel directamente a la médula espinal. cable. El estimulador se utiliza principalmente cuando los tratamientos no quirúrgicos para el dolor no logran proporcionar un alivio suficiente. Además, el dispositivo puede mejorar la calidad de vida y el sueño en general. Como normalmente se prescribe junto con otros tratamientos para el dolor, suprime eficazmente la necesidad de analgésicos. El tamaño del mercado de dispositivos estimuladores de la médula espinal se está expandiendo con el creciente número de lesiones de la médula espinal (LME) y la disponibilidad de tratamientos innovadores.
Impulsores de crecimiento y desafíos:
Según la Biblioteca Nacional de Medicina (NLM), casi Entre 250.000 y 500.000 pacientes sufren lesiones de la médula espinal cada año en todo el mundo. Según un informe publicado por la Asociación para la Investigación, Rehabilitación y Reintegración de Lesiones de la Columna Vertebral (Aspire, Reino Unido), aproximadamente 2500 personas son diagnosticadas con LME anualmente en el Reino Unido. Actualmente, aproximadamente 50.000 personas viven con estas lesiones en el Reino Unido. El Centro Nacional de Estadísticas de Lesiones de la Médula Espinal (NSCISC) estima que ~320.000 personas viven con LME traumáticas en los EE. UU. Un número elevado de casos se atribuye a las competiciones de motocross y motociclismo que se están convirtiendo en las actividades deportivas más populares en todo el mundo, según el informe del Instituto Nacional de Salud (NIH).
Además, estas lesiones son comunes en la población de edad avanzada. Según los datos presentados en la recopilación de indicadores de desarrollo del Banco Mundial en 2022, el 22,41% de la población en Alemania tiene más de 65 años. Un artículo publicado por MDPI menciona que la tasa de prevalencia de LME traumáticas es de ~500 por millón de habitantes, y la tasa de incidencia aumenta a 13 por millón en todo el mundo. Las LME tienen impactos que cambian la vida de los pacientes lesionados y sus familias. La creciente incidencia de lesiones medulares y el correspondiente tratamiento de los pacientes en los hospitales provocan al menos un reingreso del paciente cada año. Esto se debe a que las LME no se tratan de inmediato. Las causas de rehospitalización incluyen infecciones del tracto respiratorio y urinario y fracturas que ocurren durante actividades deportivas de motociclismo. Con el aumento de las LME y la disponibilidad de infraestructura bien desarrollada en centros de tratamiento que brindan programas de rehabilitación, la demanda de dispositivos de estimulación de la médula espinal está aumentando en centros especializados o de rehabilitación, impulsando el crecimiento de los dispositivos estimuladores de la médula espinal.
Perspectivas estratégicas
Segmentación y alcance del informe:
El mercado de dispositivos estimuladores de médula espinal se divide según el tipo de producto, la aplicación, el usuario final y la geografía. Según el tipo de producto, el mercado de dispositivos estimuladores de la médula espinal se divide en recargables y no recargables. El mercado de dispositivos estimuladores de la médula espinal está segmentado según su aplicación en síndrome de espalda fallida, síndrome de dolor regional complejo, enfermedad degenerativa del disco y otros. En términos de usuario final, el mercado se clasifica en hospitales, centros de cirugía ambulatoria y otros. Según la geografía, el mercado de dispositivos estimuladores de la médula espinal está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España, Rusia y el resto de Europa), Asia Pacífico (China, Japón). , India, Corea del Sur, Australia, Sudeste Asiático y resto de Asia Pacífico), Medio Oriente y África (Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de América del Sur y Central).
Análisis segmentario:
El mercado de dispositivos estimuladores de la médula espinal está segmentado según su aplicación en síndrome de espalda fallida, síndrome de dolor regional complejo, enfermedad degenerativa del disco y otros. El complejo segmento del síndrome de dolor regional tuvo la mayor participación de mercado en 2022. Se espera que registre la CAGR más alta durante 2022-2030. El síndrome de dolor regional complejo (SDRC) implica dolor e inflamación prolongados que se producen debido a una lesión u otros eventos médicos como cirugía, traumatismo, accidente cerebrovascular y ataque cardíaco. El SDRC puede ocurrir en cualquier parte del cuerpo y generalmente afecta el brazo, la pierna, la mano o el pie. Es más probable que ocurra en cualquier persona a cualquier edad, y la inflamación alcanza su punto máximo después de los 40 años. La mayoría de los casos de SDRC son causados por pequeñas fibras nerviosas periféricas de fibra C dañadas o que funcionan incorrectamente, que transportan señales de dolor al cerebro. El SDRC a menudo no se diagnostica y se desarrollan pequeños coágulos, que a veces bloquean el flujo sanguíneo a los nervios y los dañan.
Mercado de dispositivos estimuladores de la médula espinal, por aplicación: 2022 y 2030
Análisis regional:
Según la geografía, el El mercado de dispositivos estimuladores de médula espinal se divide en América del Norte, Europa, Asia Pacífico, Medio Oriente y África, y América del Sur y Central. América del Norte es el mayor contribuyente al crecimiento del mercado mundial de dispositivos estimuladores de la médula espinal. Se espera que Asia Pacífico registre la CAGR más alta en el mercado de dispositivos estimuladores de la médula espinal de 2022 a 2030. La incidencia en continuo aumento de lesiones de la médula espinal está asociada con el crecimiento de este mercado. Actualmente, las lesiones de la médula espinal suponen una importante carga para la salud en los países de América del Norte. Según Spinal Cord Inc., aproximadamente 18.000 personas en los EE. UU. sufren estas lesiones cada año.
Desarrollos de la industria y oportunidades futuras:
Las iniciativas clave de los principales actores que operan en el mercado de dispositivos estimuladores de la médula espinal se enumeran a continuación:
En agosto de 2022, Abbott Laboratories recibió la aprobación de la FDA de EE. UU. para su sistema Proclaim Plus SCS para tratar el dolor crónico. La tecnología de estimulación BurstDR permite que el dispositivo brinde un alivio superior del dolor. Ofrece la terapia FlexBurst360 que ofrece cobertura del dolor en el tronco y las extremidades; el dispositivo se puede programar según las necesidades terapéuticas cambiantes del paciente. En diciembre de 2022, el sistema de estimulación de la médula espinal (SCS) Eterna de Abbott Laboratories estará disponible para tratar el dolor crónico. La estimulación BurstDR de dosis baja de Abbott, una tecnología patentada de forma de onda SCS de dosis baja con la mayor evidencia clínica, ha sido aprobada por la FDA. Además, se ha demostrado que la técnica ayuda a reducir un 23% más el dolor que los resultados producidos por los métodos convencionales basados en tecnología de forma de onda. Panorama competitivo y empresas clave:
Algunos de los actores destacados que operan en el dispositivo estimulador de la médula espinal El mercado es Boston Scientific Corp; Nevro Corp; Laboratorios Abbott; Cirtec Medical Corp; Medtronic Plc; Biotronik SE & Co KG; Curonix LLC; Nalu Médico, Inc.; y Synapse Biomedical Inc. Estas empresas se centran en el lanzamiento de nuevos productos y expansiones geográficas para satisfacer la demanda de los consumidores globales y aumentar su gama de productos en carteras especializadas. Su presencia global les permite atender a una gran base de clientes, lo que posteriormente facilita la expansión del mercado.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Based on product type, the spinal cord stimulator device market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held a larger market share in 2022 and is expected to record a significant CAGR during 2022–2030. In terms of end users, the spinal cord stimulator device market is categorized into hospitals, ambulatory surgery centers, and others. The hospital segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR during 2022–2030.
A spinal cord stimulation device is an implanted device that relieves pain by transmitting low-level electrical signals directly into the spinal cord. The stimulator is mostly used after nonsurgical pain treatments fail to provide sufficient relief. Additionally, the device can improve the overall quality of life and sleep. As it is typically prescribed along with other pain management treatments, it effectively suppresses the need for pain medicines. The spinal cord stimulator device market size is expanding with the rising number of spinal cord injuries (SCIs) and the availability of innovative treatments.
The increasing cases of spinal cord injuries and strategic initiatives by companies bolster the spinal cord stimulator devices market size. However, the high cost associated with spinal cord stimulator devices hinders the market growth.
The spinal cord stimulator device market majorly consists of players such as Boston Scientific Corp, Nevro Corp, Abbott Laboratories, Cirtec Medical Corp, Medtronic Plc, Biotronik SE & Co KG, Curonix LLC, Nalu Medical Inc, and Synapse Biomedical Inc
Based on geography, the spinal cord stimulator device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global spinal cord stimulator device market. Asia Pacific is expected to register the highest CAGR in the spinal cord stimulator device market from 2022 to 2030.
The List of Companies - Spinal Cord Stimulator Device Market
- Boston Scientific Corp
- Nevro Corp
- Abbott Laboratories
- Cirtec Medical Corp
- Medtronic Plc
- Biotronik SE & Co KG
- Curonix LLC
- Nalu Medical, Inc.
- Synapse Biomedical Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jan 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jan 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)